Goodwin Procter advised Monte Rosa Therapeutics, while Paul Hastings advised TD Cowen and Wedbush PacGrow, as joint book-running managers, in the offering.Monte Rosa Therapeutics, Inc. executed…
Monte Rosa Therapeutics’ $100 Million Underwritten Public Offering

























